🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial is studying the side effects and best dose of intraperit...
Status
Completed
Location
University of California Medical Center At Irvine-Orange Campus
Start Date
2004-05
Trial ID
NCT00085358
Treatments Being Tested
This is a pilot study aimed to test the feasibility and safety of administe...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-04
Trial ID
NCT00787488
Treatments Being Tested
The purpose of this study is to test whether it is safe to treat your cance...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-08
Trial ID
NCT00588237
Treatments Being Tested
The purpose of this study is to evaluate giving chemotherapy drugs directly...
Status
Terminated
Location
University of Oklahoma Health Sciences Center
Start Date
2006-01
Trial ID
NCT00582205
Treatments Being Tested
Protocol No. CHLORIN E6-IIB/III-01/Protocol/1.1 Title:Single-Centre, open-l...
Status
Recruiting
Location
Creek General Hospital
Start Date
2026-04-02
Trial ID
NCT07488247
Treatments Being Tested
This clinical trial is studying how well granisetron, aprepitant, and dexam...
Status
Terminated
Location
Sudarshan K Sharma MD Limted-Gynecologic Oncology
Start Date
2011-06
Trial ID
NCT01275664
Patients will be registered prior to, during or at the completion of neoadj...
Status
Recruiting
Location
City of Hope
Start Date
2024-03-08
Trial ID
NCT05659381
Treatments Being Tested
This phase I trial studies the side effects of pressurized intraperitoneal ...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2020-08-21
Trial ID
NCT04329494
This randomized phase III trial studies bevacizumab and intravenous (given ...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2009-08-11
Trial ID
NCT00951496
This phase I trial studies the side effects and best dose of activated T-ce...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02470559
Treatments Being Tested